Resolution of the Government of Russia dated April 30, 2021, No. 687 “On state support of organizations to compensate for part of the costs associated with the certification of products, including products of the pharmaceutical and medical industry, in foreign markets” (hereinafter – “Resolution No. 687”) sets goals, conditions and procedure the provision of subsidies from the federal budget to organizations to compensate for part of the costs associated with the certification of products, including products of the pharmaceutical and medical industry, in foreign markets, within the framework of the federal project “Industrial Export” of the national project “International Cooperation and Export”.
The Russian Ministry of Health has developed a draft Rules for the Dispensing of Medicines for Medical Use” (project ID 01/02 / 04-21 / 00114788) (hereinafter referred to as the Rules).
By the ruling of the Supreme Court of the Russian Federation dated 09.21.2020 No. 310-ES20-13277 in case No. A64-3869 / 2019, it was refused to transfer the case to the Judicial Collegium for Economic Disputes of the Supreme Court. The Supreme Court confirmed the correctness of the conclusions of the Arbitration Court of the Central District, which overturned the judgments of the lower courts, which recognized the decisions of the regional Department of the Federal Antitrust Service on the groundlessness of the rejection of the bid of the procurement participant by the customer.
On April 26, 2020, Roman Shabrov, attorney at BRACE, spoke at the PHARMAPAK forum within the section “New rules of the game in the context of rapid development of e-commerce” with a report on the topic: “Current legislative framework for online trade of medicines and dietary supplements. What is allowed and what is not? Initiatives for the near future”.
On October 23, 2020, Roman Shabrov, attorney at BRACE, spoke at a webinar organized by PHARMAPAK, “Practice of reducing costs and risks during transportation and storage of medicinal products” with a report on the topic: “Actual legal risks of pharmaceutical logistics”.
- The rules for the destruction of seized falsified, substandard and counterfeit medical devices have been approved
- Certificates of registration of unlimited validity for medical devices and equipment are subject to reissuing by January 1, 2021
- Launch of the electronic service “Import of unregistered medical devices”
- The Arbitration Court of the Moscow District rejected the state customer's claim to provide a registration certificate of a combined medical device for the delivered car and mammography device